miR-16-5p Suppresses Progression and Invasion of Osteosarcoma via Targeting at Smad3
Related Experiment Video
Updated: Dec 7, 2025
Zhijian Gu1, Zhikun Li1, Ruijun Xu1
1Department of Orthopedics, Tongren Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Background:
MicroRNAs are known to regulate carcinogenesis of osteosarcoma. Although, miR-16-5p is known to exert inhibitory effects on several forms of cancers, its effects on the growth and invasion of osteosarcoma have not been studied.
Methods:
We collected human osteosarcoma specimens and adjacent tissues to detect the expression of miR-16-5p by real-time polymerase chain reaction, immunoblotting, and immunohistochemistry. The proliferation, migration, and invasion of MG63 and HOS cells following miR-16-5p overexpression and inhibition were detected with cell counting kit-8, wound healing assay, and Transwell assay, respectively. An expression vector carrying a mutated 3'-untranslated region of mothers against decapentaplegic homolog 3 (Smad3) was constructed.
Results:
The results showed that miR-16-5p expression was downregulated in osteosarcoma tissues and cells as compared with adjacent counterparts, while Smad3 was overexpressed in osteosarcoma cells. The overexpression of miR-16-5p resulted in the inhibition of the proliferation, migration, and invasion of osteosarcoma cells and enhanced the therapeutic effect of cisplatin. These effects were attenuated with miR-16-5p expression inhibition. In cells transfected with miR-16-5p mimic, Smad3 expression decreased, while this effect was absent in the cells carrying mutated Smad3.
Conclusions:
Therefore, miR-16-5p inhibits the growth and invasion of osteosarcoma by targeting Smad3.
Insights
MicroRNA-16-5p (miR-16-5p) inhibits osteosarcoma growth and invasion. This microRNA targets Smad3, offering potential therapeutic strategies for osteosarcoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- MicroRNAs play a role in osteosarcoma development.
- miR-16-5p's function in osteosarcoma growth and invasion was previously uncharacterized.
Purpose of the Study:
- To investigate the role of miR-16-5p in osteosarcoma.
- To elucidate the underlying molecular mechanisms of miR-16-5p action in osteosarcoma.
Main Methods:
- Detected miR-16-5p and Smad3 expression in osteosarcoma tissues and cells.
- Assessed the impact of miR-16-5p modulation on osteosarcoma cell proliferation, migration, and invasion.
- Utilized cell counting kit-8, wound healing, and Transwell assays.
- Constructed a mutated Smad3 expression vector to confirm target interaction.
Main Results:
- miR-16-5p was downregulated, while Smad3 was overexpressed in osteosarcoma.
- Overexpression of miR-16-5p suppressed osteosarcoma cell proliferation, migration, and invasion.
- miR-16-5p overexpression enhanced cisplatin's therapeutic efficacy.
- miR-16-5p directly targeted Smad3, reducing its expression.
Conclusions:
- miR-16-5p acts as a tumor suppressor in osteosarcoma.
- The miR-16-5p/Smad3 axis is a critical regulator of osteosarcoma progression.
- Targeting miR-16-5p presents a potential therapeutic avenue for osteosarcoma.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
MicroRNAs
MicroRNAs
TGF - β Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...


